Polymorphism in Cytochrome P4501A1 is Significantly Associated with Head and Neck Cancer Risk

REFERENCES

• Parkin D. M., Pisani P., Ferlay J. Estimates of the worldwide mortality from eighteen major cancers in 1985. Implications for prevention and projections of future burden. Int J Cancer 1993; 54: 594–606
   Web of Science ®Google Scholar
• Maier H., Dietz A., Gewelke U., Heller W. D., Weidauer H. Tobacco and alcohol and the risk of head and neck cancer. Clin Investig 1992; 70: 320–327
   PubMedGoogle Scholar
• Vecchia C. L., Tavani A., Franceschi S., Levi F., Corrao G., Negri E. Epidemiology and prevention of oral cancer. Oral Oncol 1997; 33: 302–312
   PubMed Web of Science ®Google Scholar
• International Agency for Research on Cancer. Tobacco habits other than smoking: betel quid and Areca nut chewing and some related nitrosamines. IARC Monogr Eval Carcinog Risk Chem Hum 1985; 37: 37–202
   PubMedGoogle Scholar
• Hecht S. S., Hoffmann D. Tobacco-specific nitrosamines, an important group of carcinogens in tobacco and tobacco smoke. Carcinogenesis 1988; 9: 875–884
   PubMed Web of Science ®Google Scholar
• Hecht S. S. Tobacco carcinogens, their biomarkers and tobacco-induced cancer. Nat Rev Cancer 2003; 3: 733–744
   PubMed Web of Science ®Google Scholar
• Nair U., Bartsch H., Nair J. Alert for an epidemic of oral cancer due to use of the betel quid substitutes gutkha and pan masala: a review of agents and causative mechanisms. Mutagenesis 2004; 19: 251–262
   PubMed Web of Science ®Google Scholar
• Wight A. J., Ogden G. R. Possible mechanisms by which alcohol may influence the development of oral cancer—a review. Oral Oncol 1998; 34: 441–447
   PubMed Web of Science ®Google Scholar
• Vineis P., d'Errico A., Malats N., Boffetta P. Overall evaluation and research perspectives. Metabolic Polymorphisms and Susceptibility to Cancer, P. Vineis, N. Malats, M. Lang, A. d'Errico, N. Caporaso, J. Cuzick, P. Boffetta. IARC, Lyon 1999
   Google Scholar
• Hirvonen A. Polymorphisms of xenobiotic-metabolizing enzymes and susceptibility to cancer. Environ Health Perspect 1999; 107: 37–47
   PubMed Web of Science ®Google Scholar
• Shimada T., Hayes C. L., Yamazaki H., Amin S., Hecht S. S., Guengerich F. P., Sutter T. R. Activation of chemically diverse procarcinogens by human cytochrome P-450 1B1. Cancer Res 1996; 56: 2979–2984
   PubMed Web of Science ®Google Scholar
• Fryer A. A., Jones P. W. Interactions between detoxifying enzyme polymorphisms and susceptibility to cancer. IARC Sci Publ 1999; 148: 303–322
   PubMedGoogle Scholar
• Singh A. P., Shah P. P., Mathur N., Buters J. T., Pant M. C., Parmar D. Genetic polymorphisms in cytochrome P4501B1 and susceptibility to head and neck cancer. Mutat Res 2008; 639: 11–19
   PubMed Web of Science ®Google Scholar
• Singh M., Shah P. P., Singh A. P., Ruwali M., Mathur N., Pant M. C., Parmar D. Association of genetic polymorphisms in glutathione-S-transferases and susceptibility to head and neck cancer. Mutat Res 2008; 638: 184–194
   PubMed Web of Science ®Google Scholar
• Bartsch H., Nair U., Risch A., Rojas M., Wikman H., Alexandrov K. Genetic polymorphism of CYP genes, alone or in combination, as a risk modifier of tobacco-related cancers. Cancer Epidemiol Biomarkers Prev 2000; 9: 3–28
   PubMed Web of Science ®Google Scholar
• Agundez J. A. Cytochrome P450 gene polymorphism and cancer. Curr Drug Metab 2004; 5: 211–224
   PubMed Web of Science ®Google Scholar
• Kawajiri K., Nakachi K., Imai K., Yoshii A., Shinoda N., Watanabe J. Identification of genetically high risk individuals to lung cancer by DNA polymorphisms of the cytochrome P450IA1 gene. FEBS Lett 1990; 263: 131–133
   PubMed Web of Science ®Google Scholar
• Hayashi S., Watanabe J., Kawajiri K. High susceptibility to lung cancer analyzed in terms of combined genotypes of P4501A1 and Mu-class glutathione-S-transferase genes. Jpn J Cancer Res 1992; 83: 866–870
   PubMedGoogle Scholar
• Landi M. T., Bertazzi P. A., Shields P. G., Lucier G. W. C., Garte S. J., Cosma G., Caporaso N. E. Association between CYP1A1 genotype, mRNA expression and enzymatic activity in humans. Pharmacogenetics 1994; 4: 242–246
   PubMedGoogle Scholar
• Cascorbi I., Brockmoeller J., Roots I. A. C4887A polymorphism in exon 7 of human CYP1A1: population frequency, mutation linkages, and impact on lung cancer susceptibility. Cancer Res 1996; 56: 4965–4969
   PubMed Web of Science ®Google Scholar
• Houlston R. S. CYP1A1 polymorphisms and lung cancer risk: a meta analysis. Pharmacogenetics 2000; 10: 105–114
   PubMedGoogle Scholar
• Shah P. P., Singh A. P., Singh M., Mathur N., Pant M. C., Mishra B. N., Parmar D. Interaction of cytochrome P4501A1 genotypes with other risk factors and susceptibility to lung cancer. Mutat Res 2008; 639: 1–10
   PubMed Web of Science ®Google Scholar
• Tanimoto K., Hayashi S., Yoshiga K., Ichikawa T. Polymorphisms of the CYP1A1 GSTM1 gene involved in oral squamous cell carcinoma in association with a cigarette dose. Oral Oncol 1999; 35: 191–196
   PubMed Web of Science ®Google Scholar
• Sato M., Sato T., Izumo T., Amagasa T. Genetic polymorphism of drug-metabolizing enzymes and susceptibility to oral cancer. Carcinogenesis 1999; 20: 1927–1931
   PubMed Web of Science ®Google Scholar
• Oude Ophuis M. B., van Lieshout E. M., Roelofs H. M., Peters W. H., Manni J. J. Glutathione-S-transferase M1 and T1 and cytochrome P4501A1 polymorphisms in relation to the risk for benign and malignant head and neck lesions. Cancer 1998; 82: 936–943
   PubMed Web of Science ®Google Scholar
• Ko Y., Abel J., Harth V., Brode P., Antony C., Donat S., Fischer H. P., Ortiz-Pallardo M. E., Their R., Sachinidis A., Vetter H., Bolt H. M., Herberhold C., Bruning T. Association of CYP1B1 codon 432 mutant allele in head and neck squamous cell cancer is reflected by somatic mutations of p53 in tumor tissue. Cancer Res 2001; 61: 4398–4404
   PubMed Web of Science ®Google Scholar
• Gronau S., Koenig-Greger D., Jerg M., Riechelmann H. Gene polymorphisms in detoxification enzymes as susceptibility factor for head and neck cancer. Otolaryngol Head Neck Surg 2003; 128: 674–680
   PubMed Web of Science ®Google Scholar
• Sikdar N., Mahmud S. A., Paul R. R., Roy B. Polymorphism in CYP1A1 CYP2E1 genes and susceptibility to leukoplakia in Indian tobacco users. Cancer Lett 2003; 195: 33–42
   PubMed Web of Science ®Google Scholar
• Anantharaman D., Chaubal P. M., Kannan S., Bhisey R. A., Mahimkar M. B. Susceptibility to oral cancer by genetic polymorphisms at CYP1A1 GSTM1 GSTT1 loci among Indians: tobacco exposure as a risk modulator. Carcinogenesis 2007; 28: 1455–1462
   PubMed Web of Science ®Google Scholar
• Quinones L., Lucas D., Godoy J., Caceres D., Berthou F., Varela N., Lee K., Acevedo C., Martynez L., Aguilera A. M., Gil L. CYP1A1 CYP2E1 GSTM1 genetic polymorphisms. The effect of single and combined genotypes on lung cancer susceptibility in Chilean people. Cancer Lett 2001; 174: 35–44
   PubMed Web of Science ®Google Scholar
• Hung H. C., Chuang J., Chien Y. C., Chern H. D., Chiang C. P., Kuo Y. S., Chen A., Hildesheim C. J. Genetic polymorphisms of CYP2E1 GSTM1, and GSTT1; Environmental factors and risk of oral cancer. Cancer Epidemiol Biomarkers Prev 1997; 6: 901–905
   PubMed Web of Science ®Google Scholar
• Oyama T., Mitsudomi T., Kawamoto T., Ogami A., Osaki T., Ko-dama Y., Yasumoto K. Detection of CYP1A1 gene polymorphism using designed RFLP and distributions of CYP1A1 genotypes in Japanese. Int Arch Occup Environ Health 1995; 67: 253–256
   PubMed Web of Science ®Google Scholar
• Arand M., Muhlbauer A., Hengstler J., Jäger E., Fuchs J., Winkler L., Oesch F. A multiplex polymerase chain reaction protocol for the simultaneous analysis of the glutathione-S-transferase GSTM1 and GSTT1 polymorphisms. Anal Biochem 1996; 236: 184–186
   PubMed Web of Science ®Google Scholar
• Ho T., Wei Q., Sturgis E. M. Epidemiology of carcinogen metabolism genes and risk of squamous cell carcinoma of the head and neck. Head Neck 2007; 29: 682–699
   PubMed Web of Science ®Google Scholar
• Gajecka M., Rydzanicz M., Jaskula-Sztul R., Kujawski M., Szyfter W., Szyfter K. CYP1A1 CYP2D6 CYP2E1 NAT2 GSTM1 GSTT1 polymorphisms or their combinations are associated with the increased risk of the laryngeal squamous cell carcinoma. Mutat Res 2005; 574: 112–123
   PubMed Web of Science ®Google Scholar
• Cha I. H., Park J. Y., Chung W. Y., Choi M. A., Kim H. J., Park K. K. Polymorphisms of CYP1A1 GSTM1 genes and susceptibility to oral cancer. Yonsei Med J 2007; 48: 233–239
   PubMed Web of Science ®Google Scholar
• Hashibe M., Brennan P., Strange R. C., Bhisey R., CascorbiI I., Lazarus P., Oude Ophuis M. B., Benhamou S., Foulkes W. D., Katoh T., Coutelle C., Romkes M., Gaspari L., Taioli E., Boffetta P. Meta- and pooled analyses of GSTM1 GSTT1 GSTP1, and CYP1A1 genotypes and risk of head and neck cancer. Cancer Epidemiol Biomarkers Prev 2003; 12: 1509–1517
   PubMed Web of Science ®Google Scholar
• Park J. Y., Muscat J. E., Ren Q., Schantz S. P., Harwick R. D., Stern J. C., Pike V., Richie J. P., Lazarus P. CYP1A1 GSTM1 polymorphisms and oral cancer risk. Cancer Epidemiol Biomarkers Prev 1997; 6: 791–797
   PubMed Web of Science ®Google Scholar
• Morita S., Yano M., Tsujinaka T., Akiyama Y., Taniguchi M., Kaneko K., Miki H., Fujii T., Yoshino K., Kusuoka H., Monden M. Genetic polymorphisms of drug-metabolizing enzymes and susceptibility to head-and-neck squamous-cell carcinoma. Int J Cancer 1999; 80: 685–688
   PubMed Web of Science ®Google Scholar
• Sato M., Sato T., Izumo T., Amagasa T. Genetically high susceptibility to oral squamous cell carcinoma in terms of combined genotyping of CYP1A1 GSTM1 genes. Oral Oncol 2000; 36: 267–271
   PubMed Web of Science ®Google Scholar
• Buch S. C., Notani P. N., Bhisey R. A. Polymorphism at GSTM1, GSTM3 GSTT1 gene loci and susceptibility to oral cancer in an Indian population. Carcinogenesis 2002; 23: 803–807
   PubMed Web of Science ®Google Scholar
• Hashibe M., Brennan P., Strange R. C., Bhisey R., Cascorbi I., Lazarus P., Oude Ophuis M. B., Benhamou S., Foulkes W. D., Katoh T., Coutelle C., Romkes M., Gaspari L., Taioli E., Boffetta P. Meta- and pooled analyses of GSTM1 GSTT1 GSTP1, and CYP1A1 genotypes and risk of head and neck cancer. Cancer Epidemiol Biomarkers Prev 2003; 12: 1509–1517
   PubMed Web of Science ®Google Scholar
• Cheng L., Sturgis E. M., Eicher S. A., Char D., Spitz M. R., Wei Q. Glutathione-S-transferase polymorphisms and risk of squamous cell carcinoma of head and neck. Int J Cancer 1999; 94: 220–224
   Google Scholar
• Varela-Lema L., Taioli E., Ruano-Ravina A., Barros-Dios J. M., Anantharaman D., Benhamou S., Boccia S., Bhisey R. A., Cadoni G., Capoluongo E., Chen C. J., Foulkes W., Goloni-Berfollo E. M., Hatagima A., Hayes R. B., Katoh T., Koifman S., Lazarus P., Manni J. J., Mahimkar M., Morita S., Park J., Park K. K., Pavarino Bertelli E. C., de Souza Fonseca Ribeiro E. M., Roy B., Spitz M. R., Strange R. C., Wei Q., Ragin C. C. Meta-analysis and pooled analysis of GSTM1 CYP1A1 polymorphisms and oral and pharyngeal cancers: a HuGE-GSEC review. Genet Med 2008; 10: 369–384
   PubMed Web of Science ®Google Scholar
• Schwarz D., Kisselev P., Cascorbi I., Schunck W. H., Roots I. Differential metabolism of benzo(a)pyrene and benzo(a)pyrene-7,8-dihydrodiol by human CYP1A1 variants. Carcinogenesis 2001; 22: 453–459
   PubMed Web of Science ®Google Scholar
• McGrath M., Hankinson S. E., Vivo I. D. Cytochrome P450 1A1, cigarette smoking, and risk of endometrial cancer (United States). Cancer Causes Control 2007; 18: 1123–1130
   PubMed Web of Science ®Google Scholar
• Chang L., Zheng S. L., Isaacs S. D., Turner A., Hawkins G. A., Wiley K. E., Bleecker E. R., Walsh P. C., Meyers D. A., Isaacs W. B., Xu J. Polymorphisms in the CYP1A1 gene are associated with prostate cancer risk. Int J Cancer 2003; 106: 375–378
   PubMed Web of Science ®Google Scholar
• Hashibe M., Brennan P., Benhamou S., Castellsague X., Chen C., Curado M. P., Dal Maso L., Daudt A. W., Fabianova E., Fernandez L., Wünsch-Filho V., Franceschi S., Hayes R. B., Herrero R., Koifman S., La Vecchia C., Lazarus P., Levi F., Mates D., Matos E., Menezes A., Muscat J., Eluf-Neto J., Olshan A. F., Rudnai P., Schwartz S. M., Smith E., Sturgis E. M., Szeszenia-Dabrowska N., Talamini R., Wei Q., Winn D. M., Zaridze D., Zatonski W., Zhang Z. F., Berthiller J., Boffetta P. Alcohol drinking in never users of tobacco, cigarette smoking in never drinkers, and the risk of head and neck cancer: Pooled analysis in the International Head and Neck Epidemiology Consortium. J Natl Cancer Inst 2007; 99: 777–789
   PubMed Web of Science ®Google Scholar
• Fujita K., Kamataki T. Predicting the mutagenicity of tobacco-related N-nitrosamines in humans using 11 strains of Salmonella typhimurium YG7108, each coexpressing a form of human cytochrome P450 along with NADPH-cytochrome P450 reductase. Environ Mol Mutagen 2001; 38: 339–346
   PubMed Web of Science ®Google Scholar